shroomverse
An hourglass of glass and brass with sparks of light falling quickly through it instead of sand.

THE SHROOMVERSE JOURNAL ✳ 15 MIN READ

How long does DMT last? What controlled studies measured, minute by minute

Topic: DMT

Listen: the 3-minute version

AI-narrated summary of this article

Follow the 3-minute versions on Spotify ↗

Short answer, checked 20 October 2026

In controlled studies, DMT given by injection acts within a minute or two, peaks at about 2 to 3 minutes and fades within roughly 15 to 30 minutes. Inhaled DMT in clinical trials lasted around 10 to 20 minutes. DMT is cleared fast: measured half-lives range from about 5 to 19 minutes. Ayahuasca lasts hours instead, because it contains compounds that block the enzyme (MAO-A) that normally breaks DMT down; that combination carries real risks. These are lab averages, not predictions or guidance.

THE SHORT VERSION · SWIPE

Slide 2 of 8: Lab injection study. Peak at about 2 to 3 minutes. In a 13-person London study, intensity peaked at 2 to 3 min and stayed above placebo for 17 min.
Slide 3 of 8: 1994. Almost resolved by 30 minutes. Strassman's volunteers peaked at 90 to 120 seconds; effects were almost gone by 30 minutes.
Slide 4 of 8: Half-life. 4.8 to 19 minutes. A 2025 review of human studies: DMT is eliminated rapidly, mainly by the enzyme MAO-A.
Slide 5 of 8: Ayahuasca. Hours, not minutes. With MAO-A blocked, effects peaked at 1.5 to 2 h in an 18-person study. A review gives 4 to 6 h.
Slide 6 of 8: The body. Vital signs back within 15 min. After infusions stopped, heart rate and blood pressure normalized within 15 minutes in one study.
Slide 7 of 8: Still unknown. Next-day effects untested. No study the article found tested next-day attention, sleep, mood or driving.
Slide 8 of 8: Read the full article. Sources, evidence levels and FAQs: theshroomverse.com/dmt
On this page 9 sections

DMT is known for being short, and it is one of the few psychedelics whose time course has been measured minute by minute in labs, with blood samples taken alongside ratings of how strong the effects felt. This guide sets out what those studies found: when effects start, peak and fade, how fast the body clears DMT, why ayahuasca lasts so much longer, and what is known about after-effects. For the basics of the molecule, see what is DMT.

Research summary, not guidance

This article describes published research only. It gives no amounts, no instructions and no advice on use, preparation or combinations. The timings below come from healthy volunteers in supervised clinical settings and are not a prediction for anyone. DMT is a controlled substance in Canada. For risks and where to get help, start with our safety page.

If someone may be in danger now

Call 911 if someone is unconscious, has chest pain, a seizure or trouble breathing, or if anyone’s safety is at risk. In Ontario, the Ontario Poison Centre says it is available by phone 24 hours a day, every day of the year, on 1-800-268-9017. If you or someone you know is thinking about suicide, the Government of Canada says to call or text 9-8-8, 24 hours a day, 7 days a week (Canada.ca). This article is not medical advice.

How long does DMT last?

In lab studies, minutes: effects start almost at once, peak within about 2 to 3 minutes and are gone within roughly 15 to 30 minutes when DMT is injected into a vein. The classic finding comes from Rick Strassman’s 1994 studies. Effects “began almost immediately”, peaked at 90 to 120 seconds and were almost completely resolved by 30 minutes (Strassman et al., 1994). In the companion paper, peak blood levels and effects came within 2 minutes and were negligible at 30 (Strassman and Qualls, 1994). Evidence: established.

Newer studies agree. In a London study of 13 volunteers, rated intensity peaked 2 to 3 minutes after the injection and stayed significantly above placebo for 17 minutes (Timmermann et al., 2019). In a 2026 Swiss study, single injections peaked within 2 minutes and “completely subsided within 12–30 min”, with higher amounts lasting longer (Erne et al., 2026). Evidence: established for intravenous DMT in healthy volunteers.

Inhaled (vaporized) DMT has been tested in clinical trials in Brazil. The first phase I trial describes inhaled DMT effects as lasting “around 10 min” (Falchi-Carvalho et al., 2024), and a later trial by the same group gives a short duration of action of 10 to 20 minutes (Falchi-Carvalho et al., 2025). Evidence: preliminary, from a small number of trials by one research group.

Ayahuasca, a drink that contains DMT along with other plant compounds, is a different case. In a placebo-controlled study of 18 volunteers, subjective effects peaked between 1.5 and 2 hours (Riba et al., 2003), and a 2024 review describes effects lasting 4 to 6 hours (Egger et al., 2024). Evidence: established. The reason is explained below, and ayahuasca vs DMT compares the two in full. For mushrooms, see how long magic mushrooms last.

What did the controlled studies measure?

The table lists the human studies we read, with the route, the design, the number of participants and the time course they reported. Amounts given are deliberately left out. “Infusion” means a slow, continuous drip into a vein, which researchers use to hold effects steady for longer.

Time course of DMT in controlled human studies (amounts deliberately omitted)
StudyRouteDesignPeopleTime course reported
Strassman et al., 1994 (two papers)Intravenous injectionDouble-blind, randomized, saline placebo; experienced hallucinogen users11 and 12Effects began almost immediately, peaked at 90 to 120 seconds, almost completely resolved by 30 minutes. Blood levels peaked within 2 minutes.
Timmermann et al., 2019Intravenous injectionSingle-blind, placebo first, fixed order; EEG13Peak at 2 to 3 minutes; intensity above placebo for 17 minutes.
Timmermann et al., 2023Intravenous injectionSingle-blind, placebo-controlled, counterbalanced; EEG-fMRI brain imaging20Some brain-network connectivity changes were greatest in roughly the first 1 to 6 minutes.
Vogt et al., 2023Injection, 90-minute infusion, or bothDouble-blind, randomized, placebo-controlled crossover27Injection: peak within 2 minutes, fading within 10 to 15. Infusion: plateau after 30 minutes. All effects gone within 15 minutes of stopping.
Luan et al., 2023Injection plus 30-minute infusionSingle-blind, placebo-controlled, within-subjects11Effects held through the 30-minute infusion; dose effects still detectable 12 minutes after it ended.
Erne et al., 2025120-minute infusionDouble-blind, randomized, placebo-controlled crossover22Plateau after 30 minutes; effects completely gone within 20 minutes of stopping.
van der Heijden et al., 2025Injection plus 6-hour infusionRandomized, double-blind, placebo-controlled, ascending levels29Mild effects peaked soon after the injection, then held or eased; some visual and body effects declined from about 3 hours.
Good et al., 202310-minute infusionPhase I part of a randomized, double-blind, placebo-controlled trial24Rapid peak and clearance; mean elimination half-life 9 to 12 minutes.
Erne et al., 2026Intravenous injectionDouble-blind, randomized, placebo-controlled arm plus an open-label arm20 and 16Peak within 2 minutes; effects gone within 12 to 30 minutes, longer at higher amounts.
Falchi-Carvalho et al., 2024Inhaled (vaporized)Open-label, fixed-order, ascending (phase I)27Effects described as lasting around 10 minutes.
Wießner et al., 2025Inhaled (vaporized)Randomized, double-blind, active-placebo crossover25Described as short-acting; the DMT and placebo sessions were two hours apart.
Riba et al., 2003Oral ayahuasca (freeze-dried, in capsules)Double-blind, placebo-controlled18Peak effects at 1.5 to 2 hours, matching peak DMT blood levels at 1.5 hours.

Read the table with its limits in mind. Every study is small, most enrolled healthy volunteers who had used psychedelics before, and the settings were quiet clinical rooms with medical staff. Several were single-blind or open-label, which matters because a person who knows they received DMT may rate it differently. The 2026 Swiss study found exactly that: some ratings, such as fear, tended to be higher in the blinded arm than in the open-label arm (Erne et al., 2026).

Why is DMT so short-acting?

Because the body breaks it down very quickly. A 2025 systematic review of every human pharmacokinetic study it could find (13 publications, 8 datasets) reported that DMT “is eliminated rapidly, with a half-life of 4.8–19.0 min”. It attributes this mainly to fast metabolism by the enzyme monoamine oxidase A (MAO-A), which turns DMT into indole-3-acetic acid (IAA) (van der Heijden et al., 2025, review). A half-life is the time it takes for the amount in the blood to halve. Evidence: established.

The more detailed studies see two phases. After a 90-minute infusion, DMT fell with an early half-life of about 5 to 6 minutes, then a slower late half-life of about 14 to 16 minutes; effects declined in step with the fast phase (Vogt et al., 2023). After a 120-minute infusion the figures were about 6 to 7 minutes and 18 to 19 minutes (Erne et al., 2025). Evidence: established.

A trial that did not split the phases reported a mean of 9 to 12 minutes, and lab tests in the same paper showed that blocking MAO-A slowed DMT’s breakdown (Good et al., 2023). Evidence: established that DMT is cleared within minutes; the exact figures vary by study design.

Two more findings help explain the short window. During longer infusions, blood levels kept rising while effects levelled off, which researchers read as quick acute tolerance (Vogt et al., 2023; Luan et al., 2023). And the review notes that people differ a lot, possibly because MAO-A activity varies between people, though that has not been measured directly in most studies (van der Heijden et al., 2025, review). Evidence: preliminary for what drives individual differences.

Why does ayahuasca last hours when DMT lasts minutes?

Because of one enzyme. In a 2015 study of six people, DMT given by mouth produced no psychoactive effects and no DMT in the urine: 97% of what was recovered was the MAO-A breakdown product IAA (Riba et al., 2015). A 2024 review describes DMT taken by mouth on its own as “nearly inactive” (Egger et al., 2024). Evidence: established.

Ayahuasca also contains beta-carbolines, compounds that block MAO-A. The 2003 placebo-controlled study concluded that this blocking, mainly in the gut and liver, “would suffice to prevent first-pass metabolism of DMT”, meaning the breakdown that normally happens before a swallowed drug reaches the bloodstream (Riba et al., 2003). DMT then reaches the blood slowly, peaking at 1.5 hours, in step with the peak of effects. Evidence: established for the mechanism.

The MAO-inhibitor combination carries real risks

This is an explanation of mechanism, not guidance. A 2024 review describes serotonin syndrome as “a potentially fatal crisis” of high blood pressure, fever, delirium and muscle breakdown that can occur when serotonin-acting drugs are combined with MAO inhibitors. It calls for safety measures around ayahuasca’s interactions with prescription medicines such as SSRI antidepressants, other drugs and some foods, and says ayahuasca is not recommended for people with uncontrolled high blood pressure, heart or blood-vessel disease, epilepsy, glaucoma, liver or gut disease, or during pregnancy (Egger et al., 2024). If you take any prescription medicine, ask a prescriber or pharmacist about interactions. See also our guide to magic mushrooms and antidepressants.

How long does DMT stay in your system?

In blood, not long. In the studies reviewed in 2025, blood was sampled for up to 4 hours, and in the infusion data DMT fell below the lab’s limit of measurement after about 120 minutes (van der Heijden et al., 2025, review). After a 90-minute infusion, levels dropped “very rapidly” within 15 to 20 minutes of stopping (Vogt et al., 2023). Evidence: established.

Very little leaves the body unchanged. In the one older urine study the review found (seven people, intramuscular injection), only about 0.069% of DMT was recovered unchanged in urine (van der Heijden et al., 2025, review). In the 2015 study, after inhalation, unchanged DMT made up 10% of the compounds recovered in 24-hour urine, with the rest as breakdown products (Riba et al., 2015). Evidence: preliminary, from very few small studies.

We found no verified source giving a standard detection window for DMT in routine drug tests, so we do not give one. For the mushroom version of this question, see how long shrooms stay in your system.

What after-effects were reported, and how soon were people back to baseline?

For the body, the studies report a quick return. After single injections, blood pressure and heart rate rose sharply and peaked within 2 minutes; after infusions, vital signs normalized within 15 minutes of stopping (Vogt et al., 2023). After a 6-hour infusion, raised blood pressure returned to baseline within an hour of stopping (van der Heijden et al., 2025, infusion). Strassman’s 1994 study also recorded rises in blood pressure, heart rate, pupil size, body temperature and several stress hormones (Strassman and Qualls, 1994). Evidence: established.

For the mind, most studies stopped measuring within an hour or so, and none we read tested next-day thinking or driving. The adverse effects they did record include:

  • Frequent complaints: headache, tiredness, impaired concentration, weakness, hot flashes and palpitations during long infusions (Erne et al., 2025).
  • Anxiety at onset. Single injections produced more negative effects and anxiety than slow infusions (Vogt et al., 2023). One participant in the extended-infusion study had anxiety with chest discomfort that eased within 10 minutes of stopping; follow-up heart tests were normal (Luan et al., 2023).
  • Rare lasting problems. One participant had anxiety and panic attacks the day after a 6-hour infusion and was offered counselling (van der Heijden et al., 2025, infusion). In another study, a participant’s panic attacks began shortly after the session, eased within 2 months and returned 3 months later (Erne et al., 2026). One person left a study after pre-existing tinnitus got worse (Erne et al., 2025).
  • For ayahuasca, survey data summarized in a 2024 review found challenging experiences were common and adverse psychological reactions typically subsided within a few days, though 12% of those affected sought further professional help (Egger et al., 2024).

Some trials are now testing whether a short DMT session has effects that outlast it. In one small open-label trial in Brazil (14 people with treatment-resistant depression, no control group), depression scores were lower a week later (Falchi-Carvalho et al., 2025). Without a control group that cannot show the drug caused the change. Evidence: preliminary.

What is DMT’s legal status in Canada?

DMT (N,N-dimethyltryptamine) is item 7 of Schedule III of the Controlled Drugs and Substances Act. We read the Justice Laws consolidation current to 30 September 2026 (Justice Laws, CDSA). Check the official page for any later change. This is general information, not legal advice; see is DMT legal in Canada. We found no DMT trial with a Canadian site on ClinicalTrials.gov when we searched on 20 October 2026 (ClinicalTrials.gov); the studies above were run in countries including the United States, the United Kingdom, Switzerland, the Netherlands and Brazil.

What we still don’t know

  • How long effects last outside a clinic. Every timing here comes from supervised studies, most of them using injection or infusion (unresolved).
  • How much people differ, and why. MAO-A activity is a likely factor, but the studies have not measured it directly in most participants (preliminary).
  • Next-day effects on attention, sleep, mood or driving. We found no study that tested them (unresolved).
  • How rare lasting psychological problems are. The cases above are single reports from small trials, so no rate can be given (unresolved).
  • Inhaled DMT’s exact time course. The published inhaled trials come from one research group and give approximate durations (preliminary).

The short version: in controlled studies, DMT acts in minutes and is cleared in minutes, while ayahuasca lasts hours because it blocks the enzyme that clears DMT. Check the date on this page, because DMT research is moving quickly. For background, read what are magic mushrooms or our comparison of psilocybin, LSD and DMT.

Common questions

How long does a DMT experience last in studies?

With an intravenous injection, effects peaked at about 2 to 3 minutes and were gone within roughly 15 to 30 minutes in controlled studies. Inhaled DMT in clinical trials was described as lasting around 10 to 20 minutes. These are averages from supervised healthy volunteers, not predictions.

What is the half-life of DMT?

Very short. A 2025 systematic review of human studies reported half-lives of 4.8 to 19.0 minutes. Detailed infusion studies saw a fast early phase of about 5 to 7 minutes followed by a slower phase of about 14 to 19 minutes.

Why does ayahuasca last longer than DMT?

DMT taken by mouth is normally broken down by the enzyme MAO-A before it reaches the brain. Ayahuasca contains compounds that inhibit MAO-A, so DMT survives and is absorbed slowly: in one study effects peaked at 1.5 to 2 hours, and a review describes effects lasting 4 to 6 hours. Combining MAO inhibitors with serotonin-acting drugs can cause serotonin syndrome, which can be fatal.

How long does DMT stay in your system?

DMT is cleared from blood within minutes, and in infusion studies it fell below measurable levels after about two hours. Very little leaves in urine unchanged. We found no verified source for a standard drug-test detection window, so we do not give one.

Are there after-effects of DMT?

In studies, heart rate and blood pressure returned to normal within about 15 minutes to an hour of stopping. Reported complaints included headache, tiredness and poor concentration. A few participants had lasting anxiety or panic attacks. Next-day effects have not been well studied.

Does DMT last longer than magic mushrooms?

No. In controlled studies, DMT effects last minutes, while psilocybin effects last hours. See our guides to how long magic mushrooms last and how psilocybin, LSD and DMT differ.

How long does 5-MeO-DMT last?

5-MeO-DMT is a different, also short-acting molecule. In the largest controlled trial, a 2026 study of an inhaled synthetic form called GH001, the median duration of psychoactive effect for each administration ranged from 9 to 14 minutes. That is one trial’s average, not a prediction. See what is 5-MeO-DMT for the research and its limits.

Is DMT legal in Canada?

DMT is listed as item 7 in Schedule III of the Controlled Drugs and Substances Act (consolidation current to 30 September 2026). Check the Justice Laws website for the current text. This is not legal advice.

Will DMT show up on a drug test?

Not on a standard panel. US federal rules for workplace urine tests list marijuana, cocaine, opioids, PCP and amphetamines (including MDMA); DMT and other tryptamines are not on the list. Specialist lab methods can find DMT and its breakdown products, as research studies have, but very little DMT leaves the body unchanged, and we found no verified detection window.

Shroomverse sells mushroom products. This article is general information about clinical research on DMT. It is not medical, legal or purchasing advice, and it does not recommend any product or substance.

SOURCES

  1. 49 CFR 40.85: What are the cutoff concentrations for urine drug tests?, Electronic Code of Federal Regulations (US Department of Transportation workplace testing rules). Accessed . Regulation text read via the eCFR API (version of 2026-10-01). Supports the list of urine analytes: marijuana metabolite, cocaine metabolite, codeine/morphine, hydrocodone/hydromorphone, oxycodone/oxymorphone, 6-acetylmorphine, phencyclidine, amphetamine/methamphetamine and MDMA/MDA. No tryptamine is listed. Cutoff concentrations deliberately not reproduced.
  2. Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects (Strassman RJ, Qualls CR, Archives of General Psychiatry 51(2):85–97, 1994), American Medical Association (peer-reviewed); abstract via Europe PMC, PMID 8297216. Accessed . Abstract consulted. 11 experienced users, double-blind, randomized, saline placebo; peak blood levels and effects within 2 minutes, negligible at 30 minutes; rises in blood pressure, heart rate, pupil size, temperature and hormones.
  3. Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale (Strassman RJ, et al., Archives of General Psychiatry 51(2):98–108, 1994), American Medical Association (peer-reviewed); abstract via Europe PMC, PMID 8297217. Accessed . Abstract consulted. 12 volunteers; effects began almost immediately, peaked at 90 to 120 seconds, almost completely resolved by 30 minutes.
  4. Neural correlates of the DMT experience assessed with multivariate EEG (Timmermann C, et al., Scientific Reports 9:16324, 2019), Springer Nature (peer-reviewed, open access); full text via Europe PMC, PMC6864083. Accessed . Full text consulted. 13 participants, fixed-order single-blind design; intensity above placebo for 17 minutes, peak at 2 to 3 minutes.
  5. Human brain effects of DMT assessed via EEG-fMRI (Timmermann C, et al., PNAS 120(13):e2218949120, 2023), National Academy of Sciences (peer-reviewed, open access); full text via Europe PMC, PMC10068756. Accessed . Full text consulted. 20 healthy volunteers, single-blind, placebo-controlled, counterbalanced; network connectivity increases greatest about 1 to 6 minutes after injection.
  6. Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants (Vogt SB, et al., Translational Psychiatry 13:172, 2023), Springer Nature (peer-reviewed, open access); full text via Europe PMC, PMC10206108. Accessed . Full text consulted. 27 participants, double-blind crossover; bolus peak within 2 minutes; infusion plateau after 30 minutes; effects and vital signs normal within 15 minutes of stopping; early and late half-lives 5.0–5.8 and 14–16 minutes; acute tolerance; more anxiety with bolus.
  7. Psychological and physiological effects of extended DMT (Luan LX, et al., Journal of Psychopharmacology 38(1):56–67, 2023), SAGE (peer-reviewed, open access); full text via Europe PMC, PMC10851633. Accessed . Full text consulted. 11 volunteers, single-blind, placebo-controlled; effects extended over a 30-minute infusion, dose effect for 12 minutes after; heart rate habituated within 15 minutes; one case of anxiety with chest discomfort that subsided within 10 minutes, normal ECG.
  8. Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants (Erne L, et al., Neuropsychopharmacology 50:1008–1016, 2025), Springer Nature (peer-reviewed, open access); full text via Europe PMC, PMC12032411. Accessed . Full text consulted. 22 participants, 120-minute infusions; plateau after 30 minutes, effects gone within 20 minutes of stopping; half-lives 6.3–7.1 and 18–19 minutes; common complaints; tinnitus serious adverse event.
  9. Dose-dependent pharmacokinetics and acute effects of intravenous bolus N,N-dimethyltryptamine: double-blind, randomized versus open-label dose-escalation administration study in healthy participants (Erne L, et al., Translational Psychiatry 16:213, 2026), Springer Nature (peer-reviewed, open access); full text via Europe PMC, PMC13039932. Accessed . Full text consulted. 20 randomized plus 16 open-label participants; peak within 2 minutes, subsided within 12–30 minutes, duration increased with dose; higher fear ratings in the blinded arm; one participant’s panic attacks after the session.
  10. Safety, Pharmacokinetics, and Pharmacodynamics of a 6-h N,N-Dimethyltryptamine (DMT) Infusion in Healthy Volunteers (van der Heijden KV, et al., Clinical and Translational Science 18(5):e70234, 2025), Wiley (peer-reviewed, open access); full text via Europe PMC, PMC12070030. Accessed . Full text consulted. 29 participants, randomized, double-blind, placebo-controlled; effects peaked after bolus then stable or decreasing, some declining from 3 hours; blood pressure back to baseline within 1 hour; one participant’s next-day anxiety and panic attacks.
  11. Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis (van der Heijden KV, et al., Clinical Pharmacokinetics 64:215–227, 2025), Springer (peer-reviewed, open access); full text via Europe PMC, PMC11782443. Accessed . Full text consulted. 13 publications, 8 datasets; half-life 4.8–19.0 minutes; MAO-A metabolism to IAA; sampling up to 4 hours, below quantification after 120 minutes; 0.069% unchanged in urine (one study, seven people); variability likely tied to MAO-A activity.
  12. Pharmacokinetics of N,N-dimethyltryptamine in Humans (Good M, et al., European Journal of Drug Metabolism and Pharmacokinetics 48:311–327, 2023), Springer (peer-reviewed, open access); full text via Europe PMC, PMC10122081. Accessed . Abstract and full text consulted. 24 healthy adults, 10-minute infusion, phase I part of a randomized, double-blind, placebo-controlled trial; mean elimination half-life 9–12 minutes; MAO-A inhibition reduced clearance in vitro.
  13. Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial (Falchi-Carvalho M, et al., European Neuropsychopharmacology 80:27–35, 2024), Elsevier (peer-reviewed); abstract via Europe PMC, PMID 38141403. Accessed . Abstract consulted. 27 healthy volunteers, open-label, fixed-order ascending design; inhaled DMT effects last around 10 minutes.
  14. Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial (Wießner I, et al., European Neuropsychopharmacology 97:16–27, 2025), Elsevier (peer-reviewed); abstract via Europe PMC, PMID 40532423. Accessed . Abstract consulted. 25 participants completed a randomized, double-blind, active-placebo crossover with two sessions two hours apart; short duration. A corrigendum exists (2026) that we did not read.
  15. Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression (Falchi-Carvalho M, et al., Neuropsychopharmacology 50:895–903, 2025), Springer Nature (peer-reviewed); abstract via Europe PMC, PMID 40258990. Accessed . Abstract consulted. Short duration of action of 10–20 minutes; open-label, 14 patients, no control group; lower depression scores at day 7.
  16. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics (Riba J, et al., Journal of Pharmacology and Experimental Therapeutics 306(1):73–83, 2003), ASPET (peer-reviewed); abstract via Europe PMC, PMID 12660312. Accessed . Abstract consulted. 18 volunteers, double-blind, placebo-controlled; effects peaked at 1.5–2 hours; DMT Tmax 1.5 hours; MAO inhibition in gut and liver preventing first-pass metabolism.
  17. Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study (Riba J, et al., Drug Testing and Analysis 7(5):401–406, 2015), Wiley (peer-reviewed); abstract via Europe PMC, PMID 25069786. Accessed . Abstract consulted. Six people; oral DMT gave no effects and no DMT in urine (97% IAA); after smoking, 10% unchanged DMT, 28% DMT-N-oxide, 63% IAA.
  18. Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors (Egger K, et al., Cellular and Molecular Life Sciences 81:395, 2024), Springer (peer-reviewed, open access); full text via Europe PMC, PMC11387584. Accessed . Full text consulted. Oral DMT nearly inactive; beta-carbolines block first-pass MAO-A metabolism; ayahuasca effects lasting 4–6 hours; serotonin syndrome description; interaction and contraindication cautions; survey data on challenging experiences (12% sought help).
  19. Controlled Drugs and Substances Act (S.C. 1996, c. 19), Schedule III, Government of Canada, Justice Laws Website. Accessed . Schedule III item 7, N,N-Dimethyltryptamine (DMT) and any salt thereof; consolidation current to 2026-09-30, last amended 2026-07-18.
  20. Mental health support: get help, Government of Canada (Canada.ca). Accessed . Call 9-1-1 in immediate danger; call or text 9-8-8 if thinking about suicide, 24 hours a day, 7 days a week.
  21. Ontario Poison Centre, Ontario Poison Centre. Accessed . Phone 1-800-268-9017; available 24 hours a day, every day of the year, for poison emergencies and questions.
  22. ClinicalTrials.gov search: intervention “dimethyltryptamine”, location Canada, U.S. National Library of Medicine, ClinicalTrials.gov. Accessed . Searched through the ClinicalTrials.gov v2 API on 2026-10-20 (intervention dimethyltryptamine, location Canada): zero studies returned. Used only for the statement that no DMT trial with a Canadian site was found.

CHANGES

  • : Added trip-length search wordings to keywords and an FAQ on 5-MeO-DMT duration, taken from our what is 5-MeO-DMT article (Cubała et al. 2026, median 9 to 14 minutes) and linked to it.
  • : Added an FAQ on drug tests, sourced to the US federal urine-test analyte list (49 CFR 40.85) and the article's existing urine studies.
  • : Linked glossary definitions.
  • : Published. Sources opened and checked on this date, including the CDSA consolidation current to 30 September 2026.
  • : Editorial review: the first section now opens with a direct answer; split long paragraphs and added missing evidence labels; defined first-pass metabolism; removed wording about how people typically use DMT outside studies and the named MAO-inhibiting compound; added a ClinicalTrials.gov source for the no-Canadian-trial statement; added links to the pillar, ayahuasca and Canadian law articles.